KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Capital Leases (2016 - 2018)

Exact Sciences (EXAS) has disclosed Capital Leases for 7 consecutive years, with $8.2 million as the latest value for Q4 2018.

  • On a quarterly basis, Capital Leases rose 6963.79% to $8.2 million in Q4 2018 year-over-year; TTM through Dec 2018 was $8.2 million, a 6963.79% increase, with the full-year FY2018 number at $8.2 million, up 6963.79% from a year prior.
  • Capital Leases was $8.2 million for Q4 2018 at Exact Sciences, up from $116000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $8.2 million in Q4 2018 to a low of $116000.0 in Q4 2017.
  • A 5-year average of $1.5 million and a median of $1.1 million in 2016 define the central range for Capital Leases.
  • Peak YoY movement for Capital Leases: plummeted 83.09% in 2017, then soared 6963.79% in 2018.
  • Exact Sciences' Capital Leases stood at $1.6 million in 2014, then tumbled by 34.26% to $1.1 million in 2015, then crashed by 35.34% to $686000.0 in 2016, then tumbled by 83.09% to $116000.0 in 2017, then skyrocketed by 6963.79% to $8.2 million in 2018.
  • Per Business Quant, the three most recent readings for EXAS's Capital Leases are $8.2 million (Q4 2018), $116000.0 (Q4 2017), and $224000.0 (Q3 2017).